Mark Lawler: Investing just £850 million on cancer would help save thousands of lives
Mark Lawler shared on X:
“On Budget Day, see our proposal to address the cancer carnage the previous government presided over, with their non-sensical scrapping of a cancer plan.
Targeted data-informed investment can kickstart the recovery.”
For more details click here.
Mark Lawler is the Chair in Translational Cancer Genomics and the Associate Director of Postgraduate Studies at Queen’s University Belfast, Centre for Cancer Research and Cell Biology. He is also a Visiting Professor in Human Genetics and Molecular Medicine at the University of Chieti Pescara, Italy. His specialties include genetics, molecular medicine, cancer biology, drug discovery, graduate education, bioethics, science policy, art therapy, and public perception of science.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023